In the BioHarmony Drug Report Database

"Preview" Icon

Gefitinib

Iressa (gefitinib) is a small molecule pharmaceutical. Gefitinib was first approved as Iressa on 2003-05-05. It is used to treat non-small-cell lung carcinoma in the USA. It has been approved in Europe to treat non-small-cell lung carcinoma. The pharmaceutical is active against epidermal growth factor receptor.

 

Trade Name

 

Iressa
 

Common Name

 

gefitinib
 

ChEMBL ID

 

CHEMBL939
 

Indication

 

non-small-cell lung carcinoma
 

Drug Class

 

Tyrosine kinase inhibitors

Image (chem structure or protein)

Gefitinib structure rendering